M.D. Anderson Cancer Center

NCT07513129

Phase 1Recruiting18 people6 Apr 2026clinicaltrials.gov

NCT07318324

Phase 1Recruiting31 people6 Jan 2026clinicaltrials.gov

Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS

Phase 2Recruiting48 people22 Jul 2025clinicaltrials.gov

NCT07072234

Phase 1Recruiting30 people18 Jul 2025clinicaltrials.gov

NCT07049848

Phase 2Recruiting50 people3 Jul 2025clinicaltrials.gov

NCT06930651

Phase 1/2Recruiting42 people16 Apr 2025clinicaltrials.gov

NCT06858735

Phase 2Recruiting60 people5 Mar 2025clinicaltrials.gov

NCT06760481

Phase 1Active, not recruiting7 people6 Jan 2025clinicaltrials.gov

NCT06759701

Early phase 1Recruiting30 people6 Jan 2025clinicaltrials.gov

NCT06630091

Phase 2Recruiting30 people8 Oct 2024clinicaltrials.gov

NCT06494111

Phase 2Recruiting295 people10 Jul 2024clinicaltrials.gov

NCT06383572

Phase 1/2Recruiting44 people25 Apr 2024clinicaltrials.gov

NCT06318897

Phase 2Recruiting28 people19 Mar 2024clinicaltrials.gov

NCT06284564

Phase 2Active, not recruiting10 people29 Feb 2024clinicaltrials.gov

NCT06261060

Phase 2Recruiting10 people15 Feb 2024clinicaltrials.gov

NCT06218602

Phase 2Recruiting40 people23 Jan 2024clinicaltrials.gov

NCT06207305

Phase 1/2Recruiting39 people16 Jan 2024clinicaltrials.gov

NCT06065449

Phase 3Recruiting220 people4 Oct 2023clinicaltrials.gov

NCT05977998

Phase 2Recruiting30 people7 Aug 2023clinicaltrials.gov

NCT05967182

Phase 2Recruiting24 people1 Aug 2023clinicaltrials.gov